Akums Drugs launches affordable hydroxyurea oral solution for sickle cell disease in India.
Akums Drugs and Pharmaceuticals Limited has launched India's first hydroxyurea oral solution for sickle cell disease, which will be provided to the government at a cost of R600 (less than 1% of the global price). The drug is stable at room temperature and is tailored for patients across all age groups. The Indian government has been working on a national mission to screen and manage sickle cell anaemia through early detection and effective therapies.
March 16, 2024
5 Articles